SAFETY AND PRELIMINARY EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL IN TRANSCEND NHL 001. (12th June 2019) - Wang, M.; Gordon, L.I.; Palomba, M.L.; Abramson, J.S.; Andreadis, C.; Ghosh, N.; Lunning, M.; Maloney, D.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K.; et al.